Literature DB >> 2792037

Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology.

C Maltoni1, A Ciliberti, G Cotti, B Conti, F Belpoggi.   

Abstract

In 1976, a systematic and integrated project of long-term carcinogenicity bioassays began at the Bentivoglio Experimental Unit of the Bologna Institute of Oncology. The Bologna experiments proved for the first time that benzene is an experimental carcinogen. These experiments demonstrated that benzene is carcinogenic when administered by ingestion and by inhalation and that it cause tumors in the various tested animal models (Sprague-Dawley rats, Wistar rats, Swiss mice, and RF/J mice). They also showed that benzene is a multipotential carcinogen, as it produces a variety of neoplasias in one or more of the tested animal models, including Zymbal gland carcinomas, carcinomas of the oral cavity, nasal cavities, skin, forestomach, and mammary glands, as well as angiosarcomas of the liver, hemolymphoreticular neoplasias, tumors of the lung, and possibly hepatomas. The Bologna experiments also indicated a clear-cut dose-response relationship in benzene carcinogenesis. This report presents the up-to-date results of the Bologna project. The need for more experimental research aimed at assessing the carcinogenic effects of low doses of benzene, of chemical mixtures containing benzene, and of benzene substitutes is emphasized. Also recommended are more comprehensive epidemiological investigations, extended to all types of malignancies, with particular regard to lung carcinomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792037      PMCID: PMC1568122          DOI: 10.1289/ehp.8982109

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  32 in total

1.  [Benzene leukemias in the Paris region between 1950 and 1965 (study of 50 cases)].

Authors:  A Goguel; A Cavigneaux; J Bernard
Journal:  Nouv Rev Fr Hematol       Date:  1967 Jul-Aug

2.  [Incidence of expose to benzene in severe hemopathies].

Authors:  R Girard; L Revol
Journal:  Nouv Rev Fr Hematol       Date:  1970 Jul-Aug

3.  [Comments on indemnifiction for benzene-induced leukemia and aplasia (apropos of 48 cases)].

Authors:  R Girard; G Prost; F Tolot
Journal:  Arch Mal Prof       Date:  1971-09

4.  Chromosome changes and their evolution in subjects with past exposure to benzene.

Authors:  A M Forni; A Cappellini; E Pacifico; E C Vigliani
Journal:  Arch Environ Health       Date:  1971-11

5.  Chromosome studies in workers exposed to benzene or toluene or both.

Authors:  A Fori; E Pacifico; A Limonta
Journal:  Arch Environ Health       Date:  1971-03

6.  [Malignant hemopathies and benzolism].

Authors:  R Girard; F Tolot; J Bourret
Journal:  Med Lav       Date:  1971 Feb-Mar       Impact factor: 1.275

7.  [Benzene hydrocarbons and severe hemopathies].

Authors:  R Girard; F Tolot; J Bourret
Journal:  Arch Mal Prof       Date:  1970-12

8.  [Unknown benzene exposures. Their systematic detection during severe hemopathies, (Survey of 200 hospitalized hemopathic patients)].

Authors:  R Girard; P Rigaut; J Bertholon; F Tolot; J Bourret
Journal:  Arch Mal Prof       Date:  1968-12

9.  Occupational factors in the epidemiology of leukemia in Hiroshima and Nagasaki.

Authors:  T Ishimaru; H Okada; T Tomiyasu; T Tsuchimoto; T Hoshino; M Ichimaru
Journal:  Am J Epidemiol       Date:  1971-03       Impact factor: 4.897

10.  [Chromosome studies after chronic benzol exposure].

Authors:  G Hartwich; G Schwanitz
Journal:  Dtsch Med Wochenschr       Date:  1972-01-14       Impact factor: 0.628

View more
  34 in total

1.  Evaluation of worker exposure to benzene.

Authors:  W H Hallenbeck; R E Flowers
Journal:  Bull Environ Contam Toxicol       Date:  1992-03       Impact factor: 2.151

2.  DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES.

Authors:  Ronald L Melnick; John R Bucher
Journal:  J Law Policy       Date:  2005

3.  Eccrine porocarcinoma of the thumb in a patient with chronic exposure to benzene glue.

Authors:  Sotirios Ioannidis; Antonios Antoniou; Aikaterini Patsatsi; Nikolaos Kostogloudis; Efterpi Demiri; Pericles Foroglou
Journal:  J Hand Microsurg       Date:  2014-07-06

Review 4.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

Review 5.  Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.

Authors:  Anna Csiszar; Priya Balasubramanian; Stefano Tarantini; Andriy Yabluchanskiy; Xin A Zhang; Zsolt Springo; Doris Benbrook; William E Sonntag; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-04-29       Impact factor: 7.713

6.  Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte Cultures.

Authors:  James L Wilmer; Petia P Simeonova; Dori R Germolec; Michael I Luster
Journal:  In Vitro Toxicol       Date:  1997-12

Review 7.  Polycyclic Aromatic Hydrocarbons and Breast Cancer: A Review of the Literature.

Authors:  Jessica Korsh; Allison Shen; Kristen Aliano; Thomas Davenport
Journal:  Breast Care (Basel)       Date:  2015-07-15       Impact factor: 2.860

Review 8.  Benzene-induced cancers: abridged history and occupational health impact.

Authors:  James Huff
Journal:  Int J Occup Environ Health       Date:  2007 Apr-Jun

9.  Evidence that humans metabolize benzene via two pathways.

Authors:  Stephen M Rappaport; Sungkyoon Kim; Qing Lan; Roel Vermeulen; Suramya Waidyanatha; Luoping Zhang; Guilan Li; Songnian Yin; Richard B Hayes; Nathaniel Rothman; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2009-02-19       Impact factor: 9.031

Review 10.  The toxicity of benzene and its metabolism and molecular pathology in human risk assessment.

Authors:  A Yardley-Jones; D Anderson; D V Parke
Journal:  Br J Ind Med       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.